| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $1,239,859 | 12 | 100 |
Sells | $0 | 0 | 0 |
| Treace John T. | Chief Executive Officer | 12 | $1.24M | 0 | $0 | $1.24M |
Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty System, enables surgeons to correct all three dimensions of the bunion deformity, stabilize the first TMT joint, and allow return to weight-bearing in a walking boot; minimally invasive products for four bunion classes; Nanoplasty 3D Minimally Invasive Bunion Correction System delivers a reproducible 3D correction of the bunion deformity through a cosmetically appealing; and …
Over the last 12 months, insiders at Treace Medical Concepts, Inc. have bought $1.24M and sold $0 worth of Treace Medical Concepts, Inc. stock.
On average, over the past 5 years, insiders at Treace Medical Concepts, Inc. have bought $2.1M and sold $36.59M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Treace John T. (Chief Executive Officer) — $1.24M.
The last purchase of 11,000 shares for transaction amount of $47,731 was made by Treace John T. (Chief Executive Officer) on 2026‑08‑24.
| 2026-08-24 | Treace John T. | Chief Executive Officer | 11,000 0.0168% | $4.34 | $47,731 | +2.63% | ||
| 2026-08-21 | Treace John T. | Chief Executive Officer | 5,000 0.0077% | $4.35 | $21,748 | +3.23% | ||
| 2026-08-20 | Treace John T. | Chief Executive Officer | 39,944 0.0611% | $4.44 | $177,176 | +0.45% | ||
| 2026-06-11 | Treace John T. | Chief Executive Officer | 9,891 0.0158% | $4.04 | $39,982 | +13.30% | ||
| 2026-06-10 | Treace John T. | Chief Executive Officer | 14,715 0.0216% | $4.02 | $59,213 | +4.73% | ||
| 2026-06-01 | Treace John T. | Chief Executive Officer | 50,000 0.0793% | $3.56 | $177,915 | +22.08% | ||
| 2026-05-28 | Treace John T. | Chief Executive Officer | 61,202 0.0982% | $3.02 | $184,824 | +42.37% | ||
| 2026-05-27 | Treace John T. | Chief Executive Officer | 49,810 0.0761% | $2.87 | $143,189 | +51.03% | ||
| 2026-05-26 | Treace John T. | Chief Executive Officer | 4,508 0.0067% | $2.79 | $12,576 | +54.77% | ||
| 2026-05-14 | Treace John T. | Chief Executive Officer | 61,750 0.0984% | $2.62 | $161,495 | +56.68% | ||
| 2026-05-13 | Treace John T. | Chief Executive Officer | 49,013 0.0734% | $2.46 | $120,533 | +71.34% | ||
| 2026-05-12 | Treace John T. | Chief Executive Officer | 43,000 0.0629% | $2.17 | $93,478 | +88.26% | ||
| 2025-03-17 | Sale | Scanlan Sean F. | Chief Innovation Officer | 50,000 0.0798% | $7.97 | $398,460 | -25.97% | |
| 2025-03-04 | Treace John T. | Chief Executive Officer | 60,000 0.0944% | $8.73 | $524,064 | -31.56% | ||
| 2024-09-16 | Treace John T. | Chief Executive Officer | 50,000 0.0853% | $5.31 | $265,630 | +40.92% | ||
| 2024-08-15 | TREACE JAMES T | director | 84,000 0.1435% | $5.96 | $501,035 | +12.46% | ||
| 2024-08-14 | Treace John T. | Chief Executive Officer | 85,000 0.1461% | $6.00 | $510,315 | +22.85% | ||
| 2024-06-11 | Treace John T. | Chief Executive Officer | 45,000 0.0729% | $5.88 | $264,600 | +19.32% | ||
| 2024-05-31 | TREACE JAMES T | director | 25,000 0.0415% | $6.05 | $151,328 | +18.71% | ||
| 2024-05-29 | TREACE JAMES T | director | 25,000 0.0397% | $5.20 | $130,063 | +32.20% |
| Treace John T. | Chief Executive Officer | 7404383 11.3853% | $31.69M | 25 | 15 | +24.57% |
| TREACE JAMES T | director | 1223441 1.8812% | $5.24M | 6 | 32 | +35.8% |
| MOTT RICHARD W | director | 1072944 1.6498% | $4.59M | 4 | 19 | +44.86% |
| BAKEWELL JOHN K | director | 135048 0.2077% | $578,005.44 | 1 | 0 | +59.13% |
| Jain Deepti | director | 31235 0.048% | $133,685.80 | 1 | 0 | +59.13% |
| Owens Daniel E. | 30914 0.0475% | $132,311.92 | 1 | 10 | <0.0001% | |
| Hair Mark | Chief Financial Officer | 27110 0.0417% | $116,030.80 | 1 | 1 | <0.0001% |
| Kiernan Jane E | director | 24941 0.0384% | $106,747.48 | 1 | 0 | +39.6% |
| Elder Scot Michael | *See "Remarks" | 22421 0.0345% | $95,961.88 | 1 | 2 | +9.87% |
| Berutti Aaron | Sr. VP, Sales | 13042 0.0201% | $55,819.76 | 1 | 1 | +6.89% |
| Lubben Terry W. | SVP, Operations | 5850 0.009% | $25,038.00 | 1 | 0 | +6.84% |
| Increased Positions | 60 | +37.97% | 8M | +19.62% |
| Decreased Positions | 69 | -43.67% | 11M | -27.42% |
| New Positions | 30 | New | 2M | New |
| Sold Out Positions | 34 | Sold Out | 3M | Sold Out |
| Total Postitions | 149 | -5.7% | 36M | -7.8% |
| Armistice Capital, Llc | $15,790.00 | 9.87% | 6.32M | +56,000 | +0.9% | 2025-09-30 |
| Blackrock, Inc. | $9,207.00 | 5.75% | 3.68M | -83,998 | -2.23% | 2025-09-30 |
| William Blair Investment Management, Llc | $9,086.00 | 5.68% | 3.63M | +534,486 | +17.24% | 2025-09-30 |
| Vanguard Group Inc | $6,829.00 | 4.27% | 2.73M | +6,240 | +0.23% | 2025-09-30 |
| Gagnon Securities Llc | $5,646.00 | 3.53% | 2.26M | +8,090 | +0.36% | 2025-09-30 |
| Millennium Management Llc | $4,275.00 | 2.67% | 1.71M | +192,929 | +12.72% | 2025-09-30 |
| Cibc Private Wealth Group Llc | $4,216.00 | 2.64% | 1.69M | -1,000 | -0.06% | 2025-09-30 |
| Jpmorgan Chase & Co | $4,034.00 | 2.52% | 1.61M | -163,680 | -9.21% | 2025-09-30 |
| First Eagle Investment Management, Llc | $3,097.00 | 1.94% | 1.24M | +330,866 | +36.44% | 2025-09-30 |
| Geode Capital Management, Llc | $2,866.00 | 1.79% | 1.15M | +26,826 | +2.4% | 2025-09-30 |